reductase activity alone or in combination with proximal ERp57 molecules. Notably, under steady-state conditions, the total pool of PDI in the ER is predominantly oxidized. In contrast, the oxidoreductase ERp57 (at least in the peptide-loading complex) is predominantly in the reduced state (Dick et al., 2002) . These two enzymes may collaborate to reduce (ERp57) and oxidize (PDI) MHC class I in iterations of peptide binding events that are part of editing the peptide repertoire ( Figure 1B) .
Intriguingly, unlike ERp57, PDI efficiently binds to peptides (Spee et al., 1999) and thus may have a dual role in MHC class I loading-that is, both folding and peptide delivery. Park et al. (2006) were unable to separate these activities but speculate that this could be the case for two reasons. First, preventing the binding of peptides to PDI by mutating its peptidebinding site also prevented correct oxidation of MHC class I molecules (albeit to a lesser extent). Second, blocking peptide transport into the ER inhibited MHC class I oxidation.
Possibly, peptide supply is required for PDI-directed MHC class I folding. Thus, PDI may set the trap and deliver a peptide directly to the waiting jaws of the MHC class I peptide-binding groove. It is equally possible that peptides are just cofactors for PDI activity or that the peptide-binding site of PDI represents a "foldase" active site. This remains to be established.
Finally, Park et al. (2006) provide an evolutionary argument for the relevance of PDI activity in the antigenpresentation pathway. In the "struggle for survival," human cytomegalovirus targets various steps in the MHC class I antigen-processing pathway as a stealth strategy to avoid immune detection. In prior work, Park et al. (2004) showed that one of these proteins, US3, binds to TAP, MHC class I heavy chain, and tapasin, thereby inactivating the peptide-editing function of the latter. They now show that US3 also targets PDI for degradation, thus reducing the capacity of infected cells to present antigens. PDI degradation also affects other folding processes, as "only" 15% of available PDI is busy inducing MHC class molecules to fold. As Park and colleagues elegantly demonstrate, viral interest in PDI as a target for degradation confirms the importance of chaperone proteins for successful antigen presentation under normal conditions.
Molecular chaperones, such as eukaryotic heat shock protein 90 (hsp90), promote the correct folding of client proteins. Biochemical studies have shown that hsp90 is an ATPdriven machine that cooperates with a set of cochaperones (Riggs et al., 2004) . Although the domain architecture of hsp90 is conserved between E. coli and man, none of the cochaperones that aid in hsp90 function in the eukaryotic cell have been found in prokaryotes. In this issue, Shiau et al. (2006) Molecular chaperones are cellular machines that facilitate protein folding. The crystal structures of HtpG, the Escherichia coli homolog of hsp90, reported in this issue (Shiau et al., 2006) together with the recently published structures of an hsp90-cochaperone complex and an hsp90-client protein complex , reveal exciting insights into the hsp90 reaction cycle.
teins, and a C-terminal dimerization domain. During the ATPase cycle, the three domains of hsp90 move from an ATP-free "open" state to an ATP-bound "closed" state ( Figure 1 ). Biochemical experiments suggested that a coordinated series of conformational changes occur after binding of ATP. These include the transient dimerization of the N-terminal domains and the association of the N-terminal and the middle domains (Richter et al., 2005; Pearl and Prodromou, 2006) . Consistent with this proposal, the structure of HtpG and the recently published structure of yeast hsp90, in complex with its cochaperone p23, show exactly the predicted rearrangements (Shiau et al., 2006; Ali et al. 2006 Three main structural events can be observed when the chaperone changes from the open to the closed state. Two of these movements are around hinge regions, with the domains behaving as rigid bodies. One hinge is located at the interface of the dimerized C-terminal and the middle domains. This movement radically changes the orientation of the two subunits, leading to a stronger twisting and a narrowing of the distance between the two N-terminal domains. The other twist happens at the interface of the N-terminal domain and the middle domain. Here, each N-terminal domain rotates about 90° to orient to the new dimerization interface. Lastly, there is a strand exchange between the N-terminal domains, which leads to the functional assembly of the catalytic site after nucleotide binding. Surprisingly, the HtpG crystal structure and electron micrographs show that ADP binding alone causes significant conformational changes throughout HtpG. This structure may represent an intermediate of the ATPase cycle in which ATP hydrolysis is complete but bound ADP has not yet been released. Electron micrographs also imply that a further compact ADP state likely exists in solution, which could be part of the cycle.
Most of the interactions observed by crystallography between the Nterminal domains are due to a novel conformation of the so-called "ATP lid." After ATP binding, this loop moves over the nucleotide binding site and induces a sequence of conformational changes leading to the hydrolysis of ATP (Richter et al., 2006) . The new crystal structures illustrate the remarkable flexibility of the ATP lid and indicate its possible importance for the progression of the ATPase cycle.
With the advent of eukaryotes, hsp90 apparently developed into a complex system regulated by Based on the recent structures of apo-HtpG, HtpG-ADP, and yeast hsp90-AMP-PNP, a cycle of conformational changes can be reconstituted. The slow steps during the ATPase cycle are the conformational changes preceeding ATP hydrolysis. These steps are regulated by Sti1, Cdc37 (inhibition), and Aha1 (stimulation). In contrast, the cochaperone p23 binds to the ATP-complexed and catalytically active conformation and slows down ATP turnover.
cochaperones. The structure of yeast hsp90 in a complex with its cochaperone p23/Sba1 highlights beautifully how the interaction of the cochaperone regulates the ATPase cycle of hsp90 . The p23/Sba1 cochaperone traps hsp90 at a defined step in the ATPase cycle where the nucleotide is bound, the N-terminal domains are connected via strand exchange, and the N-terminal domain interacts with the middle domain. The hsp90 protein is bound by p23/Sba1 at positions that are only created during the process of N-terminal domain dimerization. Stabilization of this conformation slows the rate of ATP turnover and as a consequence extends the half-life of the hsp90-client complex (Johnson and Toft, 1994) .
The p23/Sba1 cochaperone is just one of a large set of regulatory cochaperones. Some of them interact with specific regions in hsp90 at important points of the ATPase cycle (Figure 1 ). For example, Sti1 specifically inhibits the hsp90 ATPase by preventing the interaction of the N-terminal domains (Richter et al., 2003) . These observations suggest that cochaperones might tune the ATPase cycle of hsp90, possibly in a client-specific manner. Although none of the cochaperones is essential to drive the cycle in yeast, the efficacy of the machinery is increased by the possibility of shifting into different gears, according to client load. For some clients this may be of critical importance.
What do the new structures teach us about the client binding site in hsp90? One would have hoped to recapitulate the revelation provided by the first crystal structures of the chaperones GroEL and hsp70/DnaK. In these cases, it was relatively straightforward to identify the respective client binding sites in the crystal structures. Not so for hsp90. Neither in the yeast hsp90 structure nor in HtpG is there an unambiguous binding site. Biochemistry, too, has offered little clarity with reports indicating the binding of client proteins to each of the hsp90 domains.
All major chaperones appear to bind their clients mainly via hydrophobic binding interfaces. An interesting aspect of the hsp90 structures is that hydrophobic loops at the inner side of the hsp90 dimer are exposed in the open states-one each in the middle and C-terminal domains. They point to the inner sphere of the hsp90 dimer and would be favorably positioned to transmit nucleotideinduced conformational changes of the hsp90 dimer onto a bound client. In HtpG, these loops are subject to strong rearrangements after binding of ADP. Based on electron micrographs and image processing, even further changes are suggested for the HtpG-AMP-PNP complex.
The structure of the yeast hsp90-p23/Sba1 complex confirms the extent of these movements. In its "open" conformation, the loops occupy conformations similar to their homologs in HtpG. Addition of AMP-PNP and the cochaperone p23/Sba1 dramatically changes the arrangement of the subunits. Both of the loops in the middle and C-terminal domains change positions relative to each other. However, whether they are truly involved in client binding remains to be shown.
The first glimpse of hsp90 in a complex with a client protein is that of hsp90 bound to a kinase together with the kinase-specific cochaperone Cdc37 . Surprisingly, reconstructions based on electron micrographs showed that the complexes are asymmetric with respect to the binding of the kinase and the cochaperone. Within the limits of the resolution of electron microscopy, these data suggest that client interactions are formed simultaneously by the N-terminal and middle domains of one hsp90 monomer. One Cdc37 molecule binds to the N-terminal domain of the other hsp90 subunit. Interestingly, these interactions seem to occur on the outside of the molecule. Given the wide range of client proteins that are unrelated in structure and sequence, it is possible that there are several ways for them to interact with hsp90. This would be facilitated by flexible interaction sites on the surface of the hsp90 molecule.
The crystal structures of distinct conformational states for HtpG together with the yeast hsp90-cochaperone structure have profoundly expanded our view of the hsp90 chaperone machinery. These structures allow us to reinterpret a wealth of functional data on hsp90 and to develop new concepts concerning client activation by hsp90. In this context, the extreme asymmetry of the first three-dimensional structure of an hsp90-client complex is astonishing. Certainly, further approaches to resolve hsp90-client binding and the client-activation cycle are required.
It is known that hsp90 binds to a variety of target proteins, among them many steroid hormone receptors and kinases. The number of client proteins identified for hsp90 has been growing steadily (see http://www.picard.ch/ downloads/Hsp90interactors.pdf). Because of its many target proteins, hsp90 is considered a promising target for cancer therapy (Whitesell and Lindquist, 2005) . The recent hsp90 structures will further stimulate the search for novel therapeutic interventions that affect hsp90 function.
